Members of Omada's cardiometabolic programs can benefit from the expanded care track, the company said
First, quick refresher on orforglipron : It's FDA-approved for weight loss and management in adults with obesity or adults with overweight and at least one weight-related condition
References Thorner M, Rochiccioli P, Colle M, et al
Designed for patients graduating from Level 1 and new customers already on GLP-1 treatment and making the switch to My DX Direct
Working separately from MGHs powerhouse endocrine research laboratory, Mojsov developed a tool-kit of reliable assays that were indispensable to later in vitro and in vivo collaborative studies that established profound insulinotropic effects of this peptide family, findings that were subsequently harnessed clinically with blockbuster drugs directed at often-serious endocrine conditions such as type 2 diabetes and obesity
Journal of Controlled Release (2000).